JUL 30, 2019 11:39 AM PDT

Treating Drug-Resistant Acute Lymphoblastic Leukemia

WRITTEN BY: Nouran Amin

New therapeutics may have helped improve survival rates for acute lymphoblastic leukemia patients but some patients still remain unresponsive to existing treatment regimens. To make matters worse, drug resistance is not the only concern--the risk of drug-related toxicities among patients has pushed researchers to seek safer and effective therapeutics.

Now, scientists from Case Western Reserve University School of Medicine have developed a novel combination treatment regimen that enhances immune system function and improve the ability to kill leukemia’s that do not respond to standard protocol treatments. Findings were published in Cancer Immunology Research and describes the use of mouse models to illustrate how an antibody attaches to a specific protein on the cell surface of acute lymphoblastic leukemia cells and creates a bridge by attaching to a natural killer that quickly works to eradicate the cancer cell.

"If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatment was administered late when the tumor had grown and established its own microenvironment, the antibody alone was less effective," said Parameswaran, who is also a member of the Case Comprehensive Cancer Center and a St. Baldrick's Scholar. "There was a clear negative effect of the tumor microenvironment on natural killer cell killing capacity," Parameswaran said. "So, we added a TGF-beta receptor inhibitor to our antibody treatment regimen."

Watch this video below to learn more on acute lymphoblastic leukemia:

The treatment uses BAFF-R antibody, which attaches to the BAFF-R protein on cancer cells. The antibody is currently being used to treat autoimmune diseases and rheumatoid arthritis in two clinical trial studies.

"We looked at BAFF-R expression in a small group of 16 patients and all of them expressed this receptor. It's promising as a therapeutic avenue for late-stage disease" Parameswaran said. Data from larger patient sets will help us draw a definitive conclusion."

Source: Case Western University

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 21, 2022
Neuroscience
The Antidepressant in Everyone's Medicine Cabinet: The case for the inflammatory theory of depression grows
The Antidepressant in Everyone's Medicine Cabinet: The case for the inflammatory theory of depression grows
Compared to the countless number of serotonin and dopamine-centered depression studies, the kynurenine pathway (KP) hold ...
JAN 12, 2023
Drug Discovery & Development
Blood Pressure Drug Could Treat PTSD in Veterans
Blood Pressure Drug Could Treat PTSD in Veterans
A drug used to treat blood pressure and ADHD may be able to mitigate PTSD symptoms. The corresponding study was publishe ...
JAN 18, 2023
Technology
Artificial pancreas for type 2 diabetes management
Artificial pancreas for type 2 diabetes management
Type 2 diabetes is an increasingly common condition around the globe, affecting over 400 million people. In type 2 diabe ...
JAN 22, 2023
Neuroscience
Research Study Explores the Mysterious Causes of Pediatric Epilepsy
Research Study Explores the Mysterious Causes of Pediatric Epilepsy
Childhood epilepsy affects roughly 4% of the pediatric population, and there are many different types of epilepsy and se ...
JAN 25, 2023
Cancer
Pregnancy After, or During, Breast Cancer
Pregnancy After, or During, Breast Cancer
Breast cancer remains the most common cancer in women in the United States.  Experts estimated 287,850 breast cance ...
JAN 31, 2023
Drug Discovery & Development
Spun Threads and Computer Models Determine the Best Dose for Pancreatic Cancer Drug
Spun Threads and Computer Models Determine the Best Dose for Pancreatic Cancer Drug
We have the drug-infused threads, now these computational models can show us how to use them to treat pancreatic cancer
Loading Comments...